GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » Effective Interest Rate on Debt %

CSPC Pharmaceutical Group (FRA:CVG) Effective Interest Rate on Debt % : 5.10% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. CSPC Pharmaceutical Group's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was €5 Mil. CSPC Pharmaceutical Group's average total debt for the quarter that ended in Dec. 2023 was €91 Mil. Therefore, CSPC Pharmaceutical Group's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 5.10%.


CSPC Pharmaceutical Group Effective Interest Rate on Debt % Historical Data

The historical data trend for CSPC Pharmaceutical Group's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Effective Interest Rate on Debt % Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.16 4.82 4.03 7.33 3.92

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.79 3.04 6.06 5.90 5.10

Competitive Comparison of CSPC Pharmaceutical Group's Effective Interest Rate on Debt %

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSPC Pharmaceutical Group's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Effective Interest Rate on Debt % falls into.



CSPC Pharmaceutical Group Effective Interest Rate on Debt % Calculation

CSPC Pharmaceutical Group's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -3.326/( (78.879+90.786)/ 2 )
=-1  *  -3.326/84.8325
=3.92 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=38.86 + 40.019
=78.879

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.749 + 77.037
=90.786

CSPC Pharmaceutical Group's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Sep. 2023 )+Total Debt  (Q: Dec. 2023 ))/ count )
=-1  *  -4.632/( (0+90.786)/ 1 )
=-1  *  -4.632/90.786
=5.10 %

where

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=13.749 + 77.037
=90.786

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


CSPC Pharmaceutical Group  (FRA:CVG) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


CSPC Pharmaceutical Group Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (FRA:CVG) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (FRA:CVG) Headlines

From GuruFocus

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 05-05-2010

A cheap dutch stock - Crown van Gelder

By batbeer2 batbeer2 01-09-2011

Convergys Corp. Reports Operating Results (10-K)

By gurufocus 10qk 02-25-2011

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

Convergys Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-09-2010

WeissLaw LLP Investigates Convergys Corporation

By PRNewswire PRNewswire 06-30-2018